FL118, a Novel Camptothecin Derivative, Is Insensitive to ABCG2 Expression and Shows Improved Efficacy in Comparison With Irinotecan in Colon and Lung Cancer Models With ABCG2-induced Resistance

Molecular Cancer - United Kingdom
doi 10.1186/s12943-015-0362-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC